ELB-526

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameELB-526
Drug Alias Nameinhaled phosphodiesterase 4 inhibitor (elbion)inhaled PDE 4 inhibitor (elbion)ELB-526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElbion Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElbion NvElbion Ag
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A